Position in BMY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,528,485
-$75,586 QoQ
Shares Held
26,527
+0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#946
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOWER BRIDGE ADVISORS holds $63,752,721 across 8 Drug Manufacturers - General names. BMY ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
89,561 | $22,745,806 | |
| 2 | NVS |
Novartis AG
|
69,416 | $10,878,875 | |
| 3 | ABBV |
AbbVie Inc.
|
38,900 | $9,788,796 | |
| 4 | LLY |
ELI LILLY & Co
|
6,601 | $7,917,438 | |
| 5 | AMGN |
Amgen Inc
|
15,102 | $5,468,736 | |
| 6 | MRK |
Merck & Co., Inc.
|
34,852 | $4,478,482 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
26,527 | $1,528,485 | |
| 8 | PFE |
Pfizer Inc
|
39,290 | $946,103 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,528,485 | 26,527 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,604,071 | 26,448 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,437,393 | 26,648 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,499,484 | 33,248 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,591,079 | 34,372 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $2,217,108 | 36,352 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,784,807 | 31,556 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,670,581 | 32,288 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,365,921 | 32,890 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $2,184,113 | 40,275 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $2,127,671 | 41,467 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,804,492 | 48,320 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $3,787,246 | 59,222 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $6,260,564 | 90,327 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $6,525,793 | 90,699 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $6,449,711 | 90,726 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,038,108 | 91,404 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $6,839,186 | 93,649 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $6,185,743 | 99,210 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $6,348,349 | 107,290 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $7,315,587 | 109,482 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $7,648,515 | 121,155 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $11,786,568 | 190,014 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $9,893,227 | 164,094 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $8,938,482 | 152,015 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $8,362,560 | 150,028 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||